This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Arjun Natesan: Innovator in Creatine Prodrugs
Introduction
Arjun Natesan is a notable inventor based in Novato, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of creatine prodrugs. With a total of two patents to his name, Natesan is recognized for his innovative approaches to treating creatine deficiencies.
Latest Patents
Natesan's latest patents focus on creatine prodrugs, compositions, and methods of use thereof. The first patent provides creatine prodrug analogs and their compositions that are useful for the treatment of creatine deficiencies. The second patent reiterates this innovation, emphasizing the importance of these prodrugs in addressing health issues related to creatine levels in the body.
Career Highlights
Arjun Natesan is currently associated with Ultragenyx Pharmaceutical Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in creating solutions for individuals with creatine deficiencies.
Collaborations
Some of Natesan's notable coworkers include Yiumo Chan and Emil D Kakkis. Their collaborative efforts contribute to the innovative environment at Ultragenyx Pharmaceutical Inc.
Conclusion
Arjun Natesan's contributions to the field of creatine prodrugs highlight his role as an influential inventor. His work not only advances scientific knowledge but also provides practical solutions for health challenges related to creatine deficiencies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile